Speaks on Behalf of Atrial Fibrillation Patients at FDA Hearing on Amiodarone Replacement - For Patients. By Patients - Stop Atrial Fibrillation

On March 18, 2009, represented the atrial fibrillation patient community at the FDA Cardiovascular and Renal Drugs Advisory Committee hearings on a replacement for amiodarone. We greatly appreciate you sharing your many stories so that we could share your experiences with the FDA. I had promised to share my comments with the afib patient community, and you’ll find them here along with a summary of the hearing: Speaks on Behalf of the Atrial Fibrillation Community at FDA Hearing

Leave a Reply

Fields marked with * are required.